LAYMAN MELISSA (Chief Commercial Officer) reported 1 transaction at FLEXION THERAPEUTICS INC
Review the transaction codes below to understand the nature of each event.
Filed: 11/19/2021ACC: 0001209191-21-065708
Officer· Chief Commercial Officer
Since Mar 2020
-154.06K
Net shares
Net seller
$883.6K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
154.06K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−103.96K
Price / share
$8.50
Trade value
$883.63K
% of position
New position
11/19/2021
103.96K→0.00
Total
Net shares
−103.96K
Net value
-$883.63K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/19/2021 | D · Disposition | −103.96K | $8.50 | $883.63K | New position | 103.96K | 0.00 |
| Total | −103.96K | -$883.63K | ||||||
Derivative Transactions2
Stock Option (right to buy)
Direct
Converts to
Common Stock
30K shares
Shares
−30K
Strike price
7.01
Held after
0.00
Exercisable
—
11/19/2021
Performance Restricted Stock Unit Award
Direct
Converts to
Common Stock
20.10K shares
Shares
−20.10K
Strike price
Held after
0.00
Exercisable
—
11/19/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock30K shares | 11/19/2021 | D · Disposition | −30K | 7.01 | — | 0.00 |
| Performance Restricted Stock Unit Award Direct | Common Stock20.10K shares | 11/19/2021 | D · Disposition | −20.10K | — | 0.00 |